TABLE II.
Patient characteristic | No lymph node dissection (n = 127) | Lymph node dissection (n = 7) | P-value |
---|---|---|---|
Male gender | 20 (15.8%) | 3 (42.9%) | 0.064 |
Non-White race | 22 (17.6%) | 1 (14.3%) | 0.882 |
Positive family history | 7 (5.6%) | 0 (0.0%) | 0.522 |
History of radiation | 8 (6.4%) | 1 (14.3%) | 0.416 |
History of thyroiditis | 34 (27.4%) | 2 (28.6%) | 0.947 |
Palpable nodule | 96 (76.2%) | 7 (100.0%) | 0.142 |
Palpable lymph nodes | 1 (0.8%) | 0 (0.0%) | 0.813 |
Ultrasound focality | 74 (58.3%) | 4 (57.1%) | 0.953 |
Microcalcifications | 25 (2.02%) | 4 (57.1%) | 0.022* |
Hypervascularity | 30 (24.4%) | 0 (0.0%) | 0.136 |
Mean size in cm (ultrasound) | 2.27 (SD = 1.36) | 2.46 (SD = 1.29) | 0.722 |
Thyroid function | 0.854 | ||
Hypothyroid | 31 (25.0%) | 2 (28.6%) | |
Euthyroid | 88 (71.0%) | 5 (71.4%) | |
Hyperthyroid | 5 (4.0%) | 0 (0.0%) | |
FNAB category of nodule | 0.002* | ||
Suspicious | 32 (25.2%) | 6 (85.7%) | |
Follicular neoplasm | 42 (33.1%) | 0 (0.0%) | |
ACUS | 53 (41.7%) | 1 (14.3%) |
SD, standard deviation; ACUS, atypical cells of undetermined significance.
Statistically significant.